Rating History for Seelos Therapeutics (SEEL) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for SEEL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/21/2023 Yatin Suneja Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.31
(1.28)		 312.9% Details